CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade Recordati SPA - RECm CFD

    43.85
    0.52%
    0.15
    Low: 43.81
    High: 44.21
    Market Trading Hours* (UTC) Open now
    Closes on Friday at 16:30

    Mon - Fri: 08:00 - 16:30

    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.15
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.022079 %
    Charges from full value of position ($-4.20)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.022079%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.000143 %
    Charges from full value of position ($-0.03)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.000143%
    Overnight fee time 22:00 (UTC)
    Min traded quantity 1
    Currency EUR
    Margin 5%
    Stock exchange Italy
    Commission on trade 0%

    *Information provided by Capital.com

    Recordati Industria Chimica e Farmaceutica SpA ESG Risk Ratings

    High Medium Low Negligible

    ‘A’ score indicates excellent relative ESG performance and high degree of transparency in reporting material ESG data publicly

    More ESG coverage

    Key Stats
    Prev. Close* 44.07
    Open* 44.21
    1-Year Change* 9.05%
    Day's Range* 43.81 - 44.21
    52 wk Range 37.78-47.86
    Average Volume (10 days) 206.64K
    Average Volume (3 months) 5.20M
    Market Cap 9.28B
    P/E Ratio 24.44
    Shares Outstanding 205.53M
    Revenue 2.03B
    EPS 1.82
    Dividend (Yield %) 2.63573
    Beta 0.27
    Next Earnings Date Feb 19, 2024

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Nov 30, 2023 44.07 -0.16 -0.36% 44.23 44.47 43.89
    Nov 29, 2023 44.14 -0.12 -0.27% 44.26 44.51 44.04
    Nov 28, 2023 44.21 0.03 0.07% 44.18 44.25 43.86
    Nov 27, 2023 44.45 -0.09 -0.20% 44.54 44.89 44.35
    Nov 24, 2023 44.54 0.09 0.20% 44.45 44.61 44.28
    Nov 23, 2023 44.60 0.38 0.86% 44.22 44.64 43.95
    Nov 22, 2023 44.24 -0.68 -1.51% 44.92 44.93 44.21
    Nov 21, 2023 44.75 0.34 0.77% 44.41 44.79 44.23
    Nov 20, 2023 44.53 -0.09 -0.20% 44.62 44.89 44.36
    Nov 17, 2023 45.22 0.60 1.34% 44.62 45.62 44.44
    Nov 16, 2023 44.61 -0.13 -0.29% 44.74 44.91 44.11
    Nov 15, 2023 45.03 -0.55 -1.21% 45.58 45.90 44.94
    Nov 14, 2023 45.68 0.93 2.08% 44.75 45.89 44.64
    Nov 13, 2023 44.91 0.67 1.51% 44.24 44.94 44.21
    Nov 10, 2023 44.17 -0.19 -0.43% 44.36 44.63 43.93
    Nov 9, 2023 44.65 0.91 2.08% 43.74 44.93 43.72
    Nov 8, 2023 43.83 -1.23 -2.73% 45.06 45.82 43.61
    Nov 7, 2023 44.90 1.29 2.96% 43.61 45.44 43.61
    Nov 6, 2023 44.02 0.14 0.32% 43.88 44.30 43.51
    Nov 3, 2023 43.97 -0.09 -0.20% 44.06 44.59 43.94

    Recordati SPA Events

    Time (UTC) Country Event
    Monday, February 19, 2024

    Time (UTC)

    10:59

    Country

    IT

    Event

    Q4 2023 Recordati Industria Chimica e Farmaceutica SpA Earnings Release
    Q4 2023 Recordati Industria Chimica e Farmaceutica SpA Earnings Release

    Forecast

    -

    Previous

    -
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 1853.31 1580.07 1448.87 1481.85 1352.23
    Revenue 1853.31 1580.07 1448.87 1481.85 1352.23
    Cost of Revenue, Total 566.737 427.727 406.831 436.901 395.569
    Gross Profit 1286.57 1152.35 1042.04 1044.95 956.666
    Total Operating Expense 1411.47 1089.88 979.851 1016.58 910.016
    Selling/General/Admin. Expenses, Total 572.158 480.889 421.857 445.586 401.219
    Research & Development 220.102 166.138 146.236 77.081 67.093
    Unusual Expense (Income) 52.975 14.478 4.927 0.264 3.535
    Operating Income 441.832 490.19 469.016 465.266 442.219
    Interest Income (Expense), Net Non-Operating -40.252 -26.718 -13.203 -20.616 -17.977
    Other, Net -0.145 -0.123 -0.157 -0.506 -6.307
    Net Income Before Taxes 401.435 463.349 455.656 444.144 417.935
    Net Income After Taxes 312.336 385.966 355.027 368.866 312.422
    Minority Interest 0 0 -0.043 -0.041 -0.046
    Net Income Before Extra. Items 312.336 385.966 354.984 368.825 312.376
    Net Income 312.336 385.966 354.984 368.825 312.376
    Income Available to Common Excl. Extra. Items 312.336 385.966 354.984 368.825 312.376
    Income Available to Common Incl. Extra. Items 312.336 385.966 354.984 368.825 312.376
    Dilution Adjustment
    Diluted Net Income 312.336 385.966 354.984 368.825 312.376
    Diluted Weighted Average Shares 205.582 209.082 209.06 209.084 209.087
    Diluted EPS Excluding Extraordinary Items 1.51928 1.846 1.698 1.764 1.494
    Dividends per Share - Common Stock Primary Issue 1.15 1.1 1.05 1 0.92
    Diluted Normalized EPS 1.57912 1.89642 1.7131 1.76505 1.50664
    Depreciation / Amortization 52.6 42.6
    Other Operating Expenses, Total -0.497 0.652 0 4.15
    Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
    Total revenue 492.909 551.363 475.765 485.052 473.109
    Revenue 492.909 551.363 475.765 485.052 473.109
    Cost of Revenue, Total 148.3 163.654 143.933 154.924 152.402
    Gross Profit 344.609 387.709 331.832 330.128 320.707
    Total Operating Expense 351.991 377.95 384.224 362.353 376.788
    Selling/General/Admin. Expenses, Total 145.206 150.429 160.39 144.952 145.083
    Research & Development 58.585 60.458 64.402 56.367 55.664
    Unusual Expense (Income) 1.095 1.937 12.992 6.715 23.978
    Other Operating Expenses, Total -1.195 1.472 2.507 -0.605 -0.339
    Operating Income 140.918 173.413 91.541 122.699 96.321
    Interest Income (Expense), Net Non-Operating -11.898 -13.38 0.239 -7.103 -26.462
    Other, Net -0.091 -0.092 -0.063 -0.028 -0.027
    Net Income Before Taxes 128.929 159.941 91.717 115.568 69.832
    Net Income After Taxes 103.617 123.954 70.878 90.053 54.685
    Minority Interest 0 0 0 0 0
    Net Income Before Extra. Items 103.617 123.954 70.878 90.053 54.685
    Net Income 103.617 123.954 70.878 90.053 54.685
    Income Available to Common Excl. Extra. Items 103.617 123.954 70.878 90.053 54.685
    Income Available to Common Incl. Extra. Items 103.617 123.954 70.878 90.053 54.685
    Diluted Net Income 103.617 123.954 70.878 90.053 54.685
    Diluted Weighted Average Shares 205.421 209.029 205.417 205.602 208.895
    Diluted EPS Excluding Extraordinary Items 0.50441 0.593 0.34504 0.438 0.26178
    Dividends per Share - Common Stock Primary Issue 0 0 0.6 0 0.55
    Diluted Normalized EPS 0.55119 0.6427 0.36713 0.4423 0.29466
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total Current Assets 1173.62 850.101 772.951 809.35 699.931
    Cash and Short Term Investments 284.734 244.578 188.23 187.923 198.036
    Cash 162.636 230.924 175.227 141.384 172.421
    Cash & Equivalents 122.098 13.654 13.003 46.539 25.615
    Total Receivables, Net 424.062 350.335 313.859 374.328 281.276
    Accounts Receivable - Trade, Net 361.898 307.778 268.897 296.961 245.742
    Total Inventory 424.08 228.732 251.252 226.885 206.084
    Prepaid Expenses 17.138 15.307 12.574 10.265 8.121
    Other Current Assets, Total 23.603 11.149 7.036 9.949 6.414
    Total Assets 3998.82 2816.2 2711.65 2808.93 2161.26
    Property/Plant/Equipment, Total - Net 159.184 131.12 133.25 133.342 103.582
    Property/Plant/Equipment, Total - Gross 521.17 462.825 453.036 437.716 387.858
    Accumulated Depreciation, Total -361.986 -331.705 -319.786 -304.374 -284.276
    Goodwill, Net 780.057 553.209 562.116 577.973 577.786
    Intangibles, Net 1758.17 1138.79 1115.81 1161.76 672.106
    Long Term Investments 28.871 34.124 45.581 38.566 20.773
    Other Long Term Assets, Total 98.921 108.859 81.945 87.939 87.087
    Total Current Liabilities 923.743 626.416 578.464 586.754 490.742
    Accounts Payable 224.703 177.925 132.096 175.481 165.02
    Accrued Expenses 82.96 56.191 39.649 45.267 42.289
    Notes Payable/Short Term Debt 83.425 8.657 12.567 13.392 16.905
    Current Port. of LT Debt/Capital Leases 291.546 223.061 270.254 149.817 130.583
    Other Current Liabilities, Total 241.109 160.582 123.898 202.797 135.945
    Total Liabilities 2452.57 1434.57 1435.67 1610.35 1197.87
    Total Long Term Debt 1341.55 760.473 778.238 937.344 640.647
    Long Term Debt 1319.98 745.382 760.587 937.344 640.647
    Deferred Income Tax 167.865 26.675 41.219 43.172 43.486
    Minority Interest 0 0 0.277 0.234 0.193
    Other Liabilities, Total 19.418 21.01 37.473 42.849 22.804
    Total Equity 1546.25 1381.62 1275.98 1198.58 963.393
    Common Stock 26.141 26.141 26.141 26.141 26.141
    Additional Paid-In Capital 83.719 83.719 83.719 83.719 83.719
    Retained Earnings (Accumulated Deficit) 1785.72 1612.81 1473.6 1334.42 1161.69
    Treasury Stock - Common -149.559 -126.981 -87.516 -93.48 -145.608
    Other Equity, Total -199.769 -214.06 -219.962 -152.223 -162.545
    Total Liabilities & Shareholders’ Equity 3998.82 2816.2 2711.65 2808.93 2161.26
    Total Common Shares Outstanding 205.441 205.911 206.296 204.959 204.379
    Capital Lease Obligations 21.571 15.091 17.651
    Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
    Total Current Assets 1223.43 1449.1 1191.21 1173.62 1242.55
    Cash and Short Term Investments 302.28 528.568 231.294 284.734 346.609
    Cash & Equivalents 302.28 528.568 231.294 284.734 346.609
    Total Receivables, Net 477.028 452.948 488.17 425.813 443.062
    Accounts Receivable - Trade, Net 421.755 404.2 439.594 361.898 393.437
    Total Inventory 401.645 425.715 427.664 424.08 403.981
    Other Current Assets, Total 42.478 41.867 44.08 23.603 48.9
    Total Assets 4231.56 4208.39 3982.07 3998.82 3977.85
    Property/Plant/Equipment, Total - Net 172.976 166.251 162.311 159.184 147.226
    Property/Plant/Equipment, Total - Gross 545.511 577.44 528.919 521.17 504.681
    Accumulated Depreciation, Total -372.535 -411.189 -366.608 -361.986 -357.455
    Goodwill, Net 778.655 766.98 784.537 780.057 707.709
    Intangibles, Net 1939.79 1710.55 1725.66 1758.17 1714.51
    Long Term Investments 20.22 24.513 24.48 28.871 26.972
    Other Long Term Assets, Total 96.492 90.998 93.88 98.921 138.884
    Total Current Liabilities 955.639 950.157 880.962 923.743 778.04
    Accounts Payable 252.826 248.015 246.983 224.703 219.638
    Notes Payable/Short Term Debt 41.652 15.926 23.232 83.425 5.656
    Current Port. of LT Debt/Capital Leases 396.632 378.214 293.631 291.546 290.496
    Other Current Liabilities, Total 264.529 308.002 317.116 324.069 262.25
    Total Liabilities 2506.55 2599.16 2327.6 2452.57 2367.38
    Total Long Term Debt 1377.51 1470.52 1263.98 1341.55 1404.18
    Long Term Debt 1349.12 1441.35 1241.75 1319.98 1389.79
    Deferred Income Tax 154.255 159.213 163.737 167.865 163.776
    Minority Interest 0 0 0 0 0
    Other Liabilities, Total 19.141 19.267 18.924 19.418 21.39
    Total Equity 1725.01 1609.22 1654.47 1546.25 1610.47
    Common Stock 26.141 26.141 26.141 26.141 26.141
    Additional Paid-In Capital 83.719 83.719 83.719 83.719 83.719
    Retained Earnings (Accumulated Deficit) 1996.82 1903.48 1920.3 1785.72 1761.87
    Treasury Stock - Common -126.986 -145.52 -152.695 -149.559 -149.782
    Other Equity, Total -254.681 -258.6 -222.995 -199.769 -111.476
    Total Liabilities & Shareholders’ Equity 4231.56 4208.39 3982.07 3998.82 3977.85
    Total Common Shares Outstanding 205.53 205.535 205.358 205.441 205.459
    Prepaid Expenses 15.387
    Capital Lease Obligations 28.389 29.172 22.233 21.571 14.387
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line 312.336 385.966 355.027 368.866 312.422
    Cash From Operating Activities 461.691 492.129 403.575 318.7 357.838
    Cash From Operating Activities 27.289 25.294 25.355 25.17 13.901
    Amortization 98.467 72.291 68.317 53.078 42.959
    Deferred Taxes -6.637
    Non-Cash Items 209.716 113.194 124.979 102.747 4.697
    Changes in Working Capital -186.117 -104.616 -170.103 -231.161 -9.504
    Cash From Investing Activities -767.124 -87.499 -131.555 -441.209 -231.778
    Capital Expenditures -96.339 -87.36 -131.678 -443.288 -19.362
    Other Investing Cash Flow Items, Total -670.785 -0.139 0.123 2.079 -212.416
    Cash From Financing Activities 341.277 -355.943 -264.288 109.526 -224.688
    Financing Cash Flow Items 1.74 -2.19 0.439
    Total Cash Dividends Paid -230.602 -216.742 -212.718 -190.916 -178.887
    Issuance (Retirement) of Stock, Net -38.619 -59.308 -12.17 26.187 -149.552
    Issuance (Retirement) of Debt, Net 610.498 -79.893 -41.14 276.445 103.312
    Net Change in Cash 40.156 56.348 0.307 -10.113 -104.369
    Foreign Exchange Effects 4.312 7.661 -7.425 2.87 -5.741
    Cash Taxes Paid 89.764 91.646 65.272 140.14
    Cash Interest Paid 20.093 18.279 18.699 17.597
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line 123.954 312.336 241.458 151.405 96.72
    Cash From Operating Activities 107.923 461.691 361.692 226.113 113.431
    Cash From Operating Activities 7.004 27.289 19.675 12.895 6.016
    Amortization 27.188 98.467 70.563 44.289 18.635
    Non-Cash Items 66.727 209.716 145.296 97.032 35.714
    Cash Taxes Paid 12.33 89.764 55.992 42.515 10.653
    Cash Interest Paid 17.818 20.093 14.385 8.569 2.344
    Changes in Working Capital -116.95 -186.117 -115.3 -79.508 -43.654
    Cash From Investing Activities -14.006 -767.124 -736.385 -715.11 -722.27
    Capital Expenditures -17.557 -96.339 -83.684 -62.222 -15.599
    Other Investing Cash Flow Items, Total 3.551 -670.785 -652.701 -652.888 -706.671
    Cash From Financing Activities -144.562 341.277 452.436 601.573 571.438
    Total Cash Dividends Paid -6.139 -230.602 -120.017 -119.544 -6.219
    Issuance (Retirement) of Stock, Net -4.075 -38.619 -29.989 -16.634 -18.383
    Issuance (Retirement) of Debt, Net -134.348 610.498 602.442 737.751 596.04
    Foreign Exchange Effects -2.795 4.312 24.288 16.608 1.018
    Net Change in Cash -53.44 40.156 102.031 129.184 -36.383
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    Fimei Finanziaria Industriale Mobiliare Ed Immobiliare SpA Holding Company 51.82 108368656 0 2023-10-26 LOW
    Mawer Investment Management Ltd. Investment Advisor 4.997 10449984 -43916 2022-12-07 LOW
    Fidelity Management & Research Company LLC Investment Advisor 3.402 7114438 0 2023-10-26 LOW
    FMR Investment Management (U.K.) Limited Investment Advisor 1.7374 3633382 -3233 2023-08-31 LOW
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 1.4226 2975016 -2352 2023-09-30 LOW
    BlackRock Institutional Trust Company, N.A. Investment Advisor 1.2436 2600596 -29238 2023-09-30 LOW
    Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 0.968 2024252 293858 2022-12-31 LOW
    La Financière de l'Echiquier Investment Advisor 0.9043 1891119 388669 2023-09-30 MED
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.5711 1194378 636 2023-09-30 LOW
    BlackRock Advisors (UK) Limited Investment Advisor/Hedge Fund 0.4891 1022821 808 2023-09-30 LOW
    Amundi Asset Management, SAS Investment Advisor/Hedge Fund 0.4521 945493 9862 2023-09-30 LOW
    Manulife Investment Management (North America) Limited Investment Advisor 0.4469 934556 -23101 2023-08-31 LOW
    INVESCO Asset Management Limited Investment Advisor/Hedge Fund 0.4238 886245 2557 2023-09-30 LOW
    Invesco Advisers, Inc. Investment Advisor 0.3716 777163 -95 2023-08-31 LOW
    California Public Employees' Retirement System Pension Fund 0.3634 759886 -15901 2022-06-30 LOW
    Schroder Investment Management Ltd. (SIM) Investment Advisor/Hedge Fund 0.3411 713384 0 2023-09-30 LOW
    Walter Scott & Partners Ltd. Investment Advisor/Hedge Fund 0.3113 650906 -2616 2023-08-31 LOW
    Grandeur Peak Global Advisors, LLC Investment Advisor/Hedge Fund 0.3102 648608 158540 2023-07-31 LOW
    Epoch Investment Partners, Inc. Investment Advisor 0.3018 631174 1233 2023-09-30 LOW
    TD Asset Management Inc. Investment Advisor 0.2905 607444 149 2023-09-30 LOW

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    Recordati Company profile

    About Recordati Industria Chimica e Farma SpA

    Recordati Industria Chimica e Farmaceutica SpA is an Italy-based group engaged in the research, development, manufacture and marketing of pharmaceuticals. It promotes a wide range of pharmaceuticals, both proprietary and under license, in a number of therapeutic areas, such as Antibiotics and Antiviral, Cardiovascular, Central nervous system, Dermatological, Gastroenterology, Genital-urinary system, Muscular-skeletal disorders and pain therapy, Obstetrics and Gynecology and over the counter (OTC) pharmaceuticals. The Company is engaged in the research and development of new drug entities within the cardiovascular and urogenital therapeutic areas and of treatments for rare diseases. It’s product is ZANIDIP, a latest generation calcium-channel blocker for the treatment hypertension. It operates through Italchimici SpA, Pro Farma AG and North American marketing rights to Cystadane. The Company owns and operates through Natural Point srl also in the food supplement sector.

    Financial summary

    BRIEF: For the fiscal year ended 31 December 2021, Recordati Industria Chimica e Farma SpA revenues increased 9% to EUR1.58B. Net income increased 9% to EUR386M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Dividend per share increased from EUR1.05 to EUR1.10. Basic Earnings per Share excluding Extraordinary Items increased from EUR1.73 to EUR1.87.

    Industry: Pharmaceuticals (NEC)

    Via M. Civitali, 1
    MILANO
    MILANO 20148
    IT

    Income Statement

    • Annual
    • Quarterly

    News

    Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

    EZ PI expected to drop further but speed of decline

    08:16, 29 November 2023

    A weaker Dollar drives gold higher

    Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

    13:49, 28 November 2023

    Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

    US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

    13:20, 28 November 2023

    RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

    The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

    13:04, 28 November 2023

    Crude prices slide on OPEC+ uncertainty

    Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

    12:55, 28 November 2023
    GBP

    UK AUTUMN BUDGET: Will Hunt cut taxes? How will GBP react this time around?

    UK Chancellor Hunt will deliver the 2023 autumn statement to MPs on Wednesday 22 November.

    10:48, 21 November 2023

    Gold Rises as Traders price-in Fed Rate Cuts

    Gold prices have declined despite a drop in Treasury yields and a weaker US Dollar. We look at the key drivers and technical levels for the gold price.

    13:17, 20 November 2023

    People also watch

    XRP/USD

    0.62 Price
    +0.600% 1D Chg, %
    Long position overnight fee -0.0753%
    Short position overnight fee 0.0069%
    Overnight fee time 22:00 (UTC)
    Spread 0.01168

    Gold

    2,039.81 Price
    +0.160% 1D Chg, %
    Long position overnight fee -0.0196%
    Short position overnight fee 0.0114%
    Overnight fee time 22:00 (UTC)
    Spread 0.30

    US100

    15,928.60 Price
    +0.040% 1D Chg, %
    Long position overnight fee -0.0262%
    Short position overnight fee 0.0040%
    Overnight fee time 22:00 (UTC)
    Spread 1.8

    BTC/USD

    38,376.75 Price
    +1.450% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 22:00 (UTC)
    Spread 106.00

    Still looking for a broker you can trust?

    Join the 570.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading